Full Text Article Open Access
Citation: Saadouli D, Ben Mansour K, Zouara H, Yahyaoui S, Mahdhi S, El Afrit MA. Choroidal neovascular membrane: Report of pediatric idiopathic
case. Jr.med.res.2020;3(3): 15-19. Abid et al © All rights are reserved. https://doi.org/10.32512/jmr.3.2.2020/15.19
Submit your manuscript: www.jmedicalresearch.com
Case report
Saadouli Dorsaf
1,3, **
,
Ben Mansour Khaoula
1,3
, Zouara Haifa, Yahyaoui Salem
2,3,*
, Mahdhi Sameh
1,3
, El Afrit Mohamed Ali
1,3
.
Choroidal neovascular membrane: Report of pediatric idiopathic case.
1: Department of ophthalmology La Rabta
Hospital, Tunis, Tunisia
2: Department of Pediatrics C, Children
Hospital, Tunis, Tunisia
3: College of medicine Tunis Tunisia
* Corresponding author
** Academic Editor
Correspondence to:
yahyaouisalem@yahoo.fr
Publication Data:
Submitted: August 28,2020
Accepted: October 30,2020
Online: November 30,2020
This article was subject to full peer-
review.
This is an open access article distributed under the
terms of the Creative Commons Attribution Non-
Commercial License 4.0 (CCBY-NC) allowing sharing
and adapting.
Share: copy and redistribute the material in any
medium or format.
Adapt: remix, transform, and build upon the licensed
material.
the work provided must be properly cited and cannot
be used for commercial purpose.
The choroid neovascular membrane is a rare cause of central vision loss among
children. Its etiopathogenesis is still unclear and the management is not
standardized. The neovascularization may be due to inflammatory, post-traumatic,
or dystrophic causes. We described herein a case of choroidal neovascular
membrane in a 14-year-old boy with no evident origin after investigations.
Keywords:
choroidal neovascular membrane, idiopathic, child.
Abstract
Choroidal neovascular membrane: Report of pediatric idiopathic case.
Citation: Saadouli D, Ben Mansour K, Zouara H, Yahyaoui S, Mahdhi S, El Afrit MA. Choroidal neovascular membrane: Report of pediatric idiopathic
case. Jr.med.res.2020;3(3): 15-19. Abid et al © All rights are reserved.
Submit your manuscript: www.jmedicalresearch.com
16
Figure 2: Fluorescein angiography (FA) showed an early persistent macular dye leakage
Figure 1: Fundus photography suspected macular bilateral lesion making ½ papillary diameter suggestive of a neovascular
Membrane.
Choroidal neovascular membrane: Report of pediatric idiopathic case.
Citation: Saadouli D, Ben Mansour K, Zouara H, Yahyaoui S, Mahdhi S, El Afrit MA. Choroidal neovascular membrane: Report of pediatric idiopathic
case. Jr.med.res.2020;3(3): 15-19. Abid et al © All rights are reserved.
Submit your manuscript: www.jmedicalresearch.com
Figure 3: Linear horizontal trans-foveolar scan (Spectral HD OCT) showed a bilateral hyperreflective fibrovascular complex located above retinal
pigment epithelium layer.
Figure 3: OCT-A scan revealed a glomerular pattern CNV at the right eye and a tree-like pattern at the left eye.
17
Choroidal neovascular membrane: Report of pediatric idiopathic case.
Citation: Saadouli D, Ben Mansour K, Zouara H, Yahyaoui S, Mahdhi S, El Afrit MA. Choroidal neovascular membrane: Report of pediatric idiopathic
case. Jr.med.res.2020;3(3): 15-19. Abid et al © All rights are reserved.
Submit your manuscript: www.jmedicalresearch.com
Figure 5: Electrooculogram
Figure 3 Per-operative findings of giant pseudo meningocele and a size-increased dural defect.
18
Choroidal neovascular membrane: Report of pediatric idiopathic case.
Citation: Saadouli D, Ben Mansour K, Zouara H, Yahyaoui S, Mahdhi S, El Afrit MA. Choroidal neovascular membrane: Report of pediatric idiopathic
case. Jr.med.res.2020;3(3): 15-19. Abid et al © All rights are reserved.
Submit your manuscript: www.jmedicalresearch.com
Discussion
Choroidal neovascularization (CNV) is a neoformation of capillaries penetrating the Bruch's membrane, the retinal
pigment epithelium and later potentially into the subretinal space [1]. Pediatric choroidal neovascular membranes
(CNVM) are uncommon and may cause severe visual impairment. CNVMs may be secondary to traumatic, infectious,
inflammatory, tumoral or dystrophic causes. More than 15% of CNVMs in young patients are idiopathic [2].
Etiopathogenesis of the inappropriate proliferation of the choroidal capillaries remains unclear. The focal choroiditis
and choroidal ischemia may explain the capillaries neoformation but not the extensive behavior regarding the retinal
and subretinal spaces [3]. The diagnosis has been made easier with the introduction of the Optical coherence
tomography angiography (OCTA) that captures three-dimensional angiograms of retinal and choroidal blood vessels
and allows the detection of CNVM [4]. The management of idiopathic CNVMs is still nonconsensual due to the lack of
randomized pediatric trial. Recent reports showed promising stable anatomical and visual outcomes with the anti-
vascular endothelial growth factor therapy (VEGF) [5,6].
Conflict of Interest: None
References
[1] Dutta Majumder P, Ghose A, Rao C, Bhende M, Biswas J. A case of choroidal neovascular membrane in 6-year-old boy with juvenile idiopathic arthritis. J Ophthalmic Inflamm
Infect. 2017; 7:18.
[2] Ong SS, Hsu ST, Grewal D, Arevalo JF, El-Dairi MA, Toth CA, Vajzovic L. Appearance of pediatric choroidal neovascular membranes on optical coherence tomography
angiography. Graefes Arch Clin Exp Ophthalmol. 2020; 258:89-98.
[3] Yeo NJY, Chan EJJ, Cheung C. Choroidal Neovascularization: Mechanisms of Endothelial Dysfunction. Front Pharmacol. 2019; 10:1363.
[4] Venkat AG, Ehlers JP, Kaiser PK, Singh RP, Schachat AP, Srivastava SK, Martin DF, Rachitskaya AV. Detection of choroidal neovascular membrane beneath pigment epithelial
detachment using SD-OCTA. Ophthalmic Surg Lasers Imaging Retina. 2019; 50:620-26.
[5] Dʼsouza P, Ranjan R, Babu U, Kanakath AV, Saravanan VR. Inflammatory neovascular membrane: Long-term visua and anatomical outcomes after intravitreal anti-vascular
endothelial growth factor therapy. Retina. 2018; 38:1307-15.
[6] Chrapek O, Vostrovská Z, Šínová I, Chrapková B. Treatment of idiopathic choroidal neovascular membrane with ranibizumab - our experience. Cesk Slov Oftalmol. 2019;
75:25-29.
19